Literature DB >> 15638116

Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance.

K Szocs1.   

Abstract

Reactive oxygen species (ROS), as superoxide and its metabolites, have important roles in vascular homeostasis as they are involved in various signaling processes. In many cardiovascular disease states, however, the release of ROS is increased. Uncontrolled ROS production leads to impaired endothelial function and consequently to vascular dysfunction. This review focuses on two clinical conditions associated with elevated ROS levels: ischemia/reperfusion and nitrate tolerance. Injury caused by ischemia/reperfusion is an important limitation of transplantations, and complicates the management of stroke and myocardial infarction. Nitrates, which are used to treat transient myocardial ischemia (angina pectoris), decrease in efficacy in long-term continuous administration. There are several enzyme systems, such as xanthine oxidase, cyclooxygenase, uncoupled endothelial nitric oxide synthase, NAD(P)H oxidase, cytochrome P450 and the mitochondrial electron transport chain, which are responsible for the increased vascular production of superoxide. The contribution of particular ROS producing enzymes and the effect of antioxidant treatment are discussed in both pathological conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15638116

Source DB:  PubMed          Journal:  Gen Physiol Biophys        ISSN: 0231-5882            Impact factor:   1.512


  32 in total

Review 1.  Lung ischemia: a model for endothelial mechanotransduction.

Authors:  Shampa Chatterjee; Kenneth E Chapman; Aron B Fisher
Journal:  Cell Biochem Biophys       Date:  2008-11-04       Impact factor: 2.194

2.  A mechanistic mathematical model for the catalytic action of glutathione peroxidase.

Authors:  V R Pannala; J N Bazil; A K S Camara; R K Dash
Journal:  Free Radic Res       Date:  2014-02-24

3.  Nobiletin Protects from Renal Ischemia-Reperfusion Injury in Rats by Suppressing Inflammatory Cytokines and Regulating iNOS-eNOS Expressions.

Authors:  Mehmet Güvenç; Mustafa Cellat; Ahmet Uyar; Hüseyin Özkan; İshak Gokcek; Cafer Tayer İsler; Akın Yakan
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

4.  Green tea polyphenol extract attenuates ischemia/reperfusion injury of the gut.

Authors:  Carmelo Muià; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Marta Menegazzi; Achille P Caputi; Hisanori Suzuki; Salvatore Cuzzocrea
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-05       Impact factor: 3.000

Review 5.  Cellular and molecular mechanisms of endothelial ischemia/reperfusion injury: perspectives and implications for postischemic myocardial protection.

Authors:  Qin Yang; Guo-Wei He; Malcolm John Underwood; Cheuk-Man Yu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

6.  Induced peroxidase and cytoprotective enzyme expressions support adaptation of HUVECs to sustain subsequent H2O2 exposure.

Authors:  Hemang Patel; Juan Chen; Mahendra Kavdia
Journal:  Microvasc Res       Date:  2015-09-25       Impact factor: 3.514

7.  Overexpression of Fibulin-5 Attenuates Ischemia/Reperfusion Injury After Middle Cerebral Artery Occlusion in Rats.

Authors:  Jia Guo; Chuang Cheng; Cindy Si Chen; Xiangfeng Xing; Guanghui Xu; Jinzhou Feng; Xinyue Qin
Journal:  Mol Neurobiol       Date:  2015-05-30       Impact factor: 5.590

Review 8.  Lipid raft redox signaling: molecular mechanisms in health and disease.

Authors:  Si Jin; Fan Zhou; Foad Katirai; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

Review 9.  Role of nitroso radicals as drug targets in circulatory shock.

Authors:  Emanuela Esposito; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

10.  Cryptotanshinone inhibits oxidized LDL-induced adhesion molecule expression via ROS dependent NF-κB pathways.

Authors:  Wenwen Zhao; Chuanhong Wu; Xiuping Chen
Journal:  Cell Adh Migr       Date:  2015-12-08       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.